Search results: Sage Journals

Restricted accessOtherFirst published April, 1990

Design of Phase I and II Trials in Cancer

Nancy L. Geller

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published November, 2004

Monitoring Participant Safety in Phase I and II Interventional Trials: Options and Controversies

Patricia L. Hibberd, Debra L. Weiner

Journal of Investigative Medicine

Restricted accessResearch articleFirst published June, 2024

Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies

Yong Zang, Beibei Guo, Yingjie Qiu [...]

Clinical Trials

Restricted accessResearch articleFirst published March, 2021

CWL: A conditional weighted likelihood method to account for the delayed joint toxicity–efficacy outcomes for phase I/II clinical trials

Yifei Zhang, Yong Zang

Statistical Methods in Medical Research

Open accessResearch articleFirst published June, 2024

Risk–benefit trade-offs and precision utilities in phase I-II clinical trials

Pavlos Msaouel, Juhee Lee, Peter F Thall

Clinical Trials

Restricted accessResearch articleFirst published July, 2025

A model-free phase I/II dose optimization design for immunotherapy trials

Yingjie Qiu, Mengyi Lu, Yan Han [...]

Statistical Methods in Medical Research

Restricted accessResearch articleFirst published March, 2023

Shotgun-2: A Bayesian phase I/II basket trial design to identify indication-specific optimal biological doses

Xin Chen, Jingyi Zhang, Liyun Jiang [...]

Statistical Methods in Medical Research

Open accessResearch articleFirst published February, 2021

Details of risk–benefit communication in informed consent documents for phase I/II trials

Hannes Kahrass, Sabine Bossert, Christopher Schürmann [...]

Clinical Trials

Restricted accessResearch articleFirst published April, 1996

Phase I and II Trials: Designs and Strategies

Wayne A. Colburn

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2014

Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding Objectives

Oleksandr Sverdlov, Weng Kee Wong

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published April, 1990

Design of Phase I and II Trials in Cancer

Nancy L. Geller

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published November, 2004

Monitoring Participant Safety in Phase I and II Interventional Trials: Options and Controversies

Patricia L. Hibberd, Debra L. Weiner

Journal of Investigative Medicine

Restricted accessResearch articleFirst published June, 2024

Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies

Yong Zang, Beibei Guo, Yingjie Qiu [...]

Clinical Trials

Restricted accessResearch articleFirst published March, 2021

CWL: A conditional weighted likelihood method to account for the delayed joint toxicity–efficacy outcomes for phase I/II clinical trials

Yifei Zhang, Yong Zang

Statistical Methods in Medical Research

Open accessResearch articleFirst published June, 2024

Risk–benefit trade-offs and precision utilities in phase I-II clinical trials

Pavlos Msaouel, Juhee Lee, Peter F Thall

Clinical Trials

Restricted accessResearch articleFirst published July, 2025

A model-free phase I/II dose optimization design for immunotherapy trials

Yingjie Qiu, Mengyi Lu, Yan Han [...]

Statistical Methods in Medical Research

Restricted accessResearch articleFirst published March, 2023

Shotgun-2: A Bayesian phase I/II basket trial design to identify indication-specific optimal biological doses

Xin Chen, Jingyi Zhang, Liyun Jiang [...]

Statistical Methods in Medical Research

Open accessResearch articleFirst published February, 2021

Details of risk–benefit communication in informed consent documents for phase I/II trials

Hannes Kahrass, Sabine Bossert, Christopher Schürmann [...]

Clinical Trials

Restricted accessResearch articleFirst published April, 1996

Phase I and II Trials: Designs and Strategies

Wayne A. Colburn

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2014

Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding Objectives

Oleksandr Sverdlov, Weng Kee Wong

Therapeutic Innovation & Regulatory Science